roxarsone has been researched along with Angiogenesis, Pathologic in 6 studies
Roxarsone: An arsenic derivative which has anticoccidial action and promotes growth in animals.
roxarsone : An organoarsonic acid where the organyl group is 4-hydroxy-3-nitrophenyl.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Roxarsone has a low absorption rate and is mostly excreted with feces, which could pose a risk to human health through environmental and animal food routes." | 1.72 | The VEGFR2/mTOR/S6K1 pathway involved in the angiogenic effects of roxarsone in vitro and in vivo. ( Chen, B; Chen, X; Ding, L; Liu, C; Wang, C; Zhang, M; Zhang, Y; Zhou, Z, 2022) |
| "Roxarsone is an organoarsenic feed additive used in livestock and poultry production that is released into the environment, where it poses a risk to human health." | 1.48 | Tumor-promoting and pro-angiogenic effects of roxarsone via VEGFR2/PLCĪ³/PKC signaling. ( Chenlin, Z; Lei, W; Pang, Y; Wang, K; Wang, Y; Zhang, Y, 2018) |
| "Roxarsone was found to exhibit a higher angiogenic index than As(III) at lower concentrations." | 1.35 | Angiogenic potential of 3-nitro-4-hydroxy benzene arsonic acid (roxarsone). ( Barchowsky, A; Basu, P; Ghosh, RN; Grove, LE; Klei, L, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, M | 1 |
| Ding, L | 1 |
| Zhou, Z | 1 |
| Liu, C | 1 |
| Wang, C | 1 |
| Chen, B | 1 |
| Chen, X | 2 |
| Zhang, Y | 5 |
| Chen, S | 1 |
| Xu, J | 1 |
| Wei, Q | 1 |
| Zhao, Z | 1 |
| Cui, H | 1 |
| Pang, Y | 1 |
| Wang, K | 1 |
| Wang, Y | 2 |
| Chenlin, Z | 1 |
| Lei, W | 1 |
| Zhu, J | 2 |
| Cui, W | 2 |
| Liu, X | 1 |
| Ying, J | 1 |
| Hu, C | 1 |
| Lu, Q | 1 |
| Xin, W | 1 |
| Basu, P | 1 |
| Ghosh, RN | 1 |
| Grove, LE | 1 |
| Klei, L | 1 |
| Barchowsky, A | 1 |
6 other studies available for roxarsone and Angiogenesis, Pathologic
| Article | Year |
|---|---|
The VEGFR2/mTOR/S6K1 pathway involved in the angiogenic effects of roxarsone in vitro and in vivo.
Topics: Animals; Cell Proliferation; Endothelial Cells; Human Umbilical Vein Endothelial Cells; Humans; Mice | 2022 |
VEGF/Flk1 Mechanism is Involved in Roxarsone Promotion of Rat Endothelial Cell Growth and B16F10 Xenograft Tumor Angiogenesis.
Topics: Animals; Antigens, CD34; Cell Line, Tumor; Endothelial Cells; Gene Expression; Melanoma, Experimenta | 2019 |
Tumor-promoting and pro-angiogenic effects of roxarsone via VEGFR2/PLCĪ³/PKC signaling.
Topics: Animals; Blotting, Western; Cell Line, Tumor; Humans; Mice; Mice, Inbred C57BL; Mutagens; Neovascula | 2018 |
In vitro and ex vivo angiogenic effects of roxarsone on rat endothelial cells.
Topics: Animals; Aorta; Blotting, Western; Cell Proliferation; Cell Survival; Cells, Cultured; Endothelial C | 2013 |
Organoarsenic Roxarsone Promotes Angiogenesis In Vivo.
Topics: Animals; Cell Survival; Cells, Cultured; Chickens; Chorioallantoic Membrane; Endothelial Cells; Fema | 2016 |
Angiogenic potential of 3-nitro-4-hydroxy benzene arsonic acid (roxarsone).
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Endothelial Cells; Humans; Neovascularizati | 2008 |